» Articles » PMID: 17558045

Vitiligo: Compendium of Clinico-epidemiological Features

Overview
Date 2007 Jun 15
PMID 17558045
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Vitiligo, an autoimmune disorder characterized by localized and/or generalized depigmentation of the skin and/or mucous membranes, is a well-recognized entity. The imperatives of its epidemiology both in rural India and in global reckoning have been highlighted frequently. Its morphology is striking and is characterized by asymptomatic ivory/chalky white macule(s) that may be frequently surrounded by a prominent pigmented border, the 'trichrome vitiligo'. However vitiligo may have morphological variations in the form of: trichrome, quadri-chrome, penta-chrome, blue and inflammatory vitiligo. Its current topographical classification into segmental, zosteriform and nonsegmental, areata, vulgaris, acrofacialis and mucosal represent its well acclaimed presentations. Its adult and childhood onset is well appreciated as also its presentation in males and females. Occasionally, it may be possible to identify triggering factors. Vitiligo may be associated with cutaneous, ocular and systemic disorders, the details of which are discussed in this article.

Citing Articles

Excimer light versus excimer light plus trichloroacetic acid for vitiligo treatment: A comparative study.

Dayel S, Hammad R, Hussein R, Badawy S, Abahussein O, Ali El-Sherbiny A Medicine (Baltimore). 2025; 104(10):e41774.

PMID: 40068021 PMC: 11902949. DOI: 10.1097/MD.0000000000041774.


Microneedling and 5-Fluorouracil in Treating Stable Vitiligo in Hitherto Unstudied High Prevalence Population.

Abhirami B, Kumar P, Mishra D Indian J Dermatol. 2024; 69(5):377-384.

PMID: 39649967 PMC: 11623419. DOI: 10.4103/ijd.ijd_1056_23.


Updates on the Association Between Vitiligo and Thyroid Diseases: A Systematic Review.

Abuhalimeh R, Alshmrani L, Abdullah N, Alqahtani A, AlQarni S, Aljuaid M Cureus. 2024; 16(9):e69697.

PMID: 39429364 PMC: 11490285. DOI: 10.7759/cureus.69697.


Short-term (24 weeks) treatment efficacy and safety of ruxolitinib cream in participants with vitiligo: a systematic review and meta-analysis.

Yuan Y, Zhang Y, Zheng L, Gu X, Yu S, Sun X Syst Rev. 2024; 13(1):250.

PMID: 39358803 PMC: 11445846. DOI: 10.1186/s13643-024-02653-7.


Similar Seasonality in Childhood-Onset, Pediatric, and Adulthood-Onset Vitiligo: A Common Data Model Analysis of 16 Real-World Databases.

Lee Y, Lee Y, Kim M, Lew B, Kwon S Ann Dermatol. 2024; 36(5):326-328.

PMID: 39343761 PMC: 11439979. DOI: 10.5021/ad.23.076.